Condition | Intervention | Phase |
---|---|---|
Relapsing Remitting Multiple Sclerosis | Drug: RHB-104 | Phase 2 |
Study Type: | Interventional |
Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
Official Title: | A Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of Fixed Dose Combination RHB-104 as Add-On Therapy to Interferon Beta-1a in Patients Treated for Relapsing Remitting Multiple Sclerosis |
Labels: clarithryomycin, clofazimine, Crohn's, mycobactrium paratunerculsosi, RHB-104, rifabutin